New trial aims to treat both liver damage and alcohol addiction at once
Disease control
Recruiting now
This study tests whether adding alcohol use disorder treatments (acamprosate and counseling) to standard liver therapy improves outcomes for people with severe alcohol-associated hepatitis. It also compares a new drug, F-652, against prednisone for liver treatment. About 216 adul…
Phase: PHASE2 • Sponsor: Samer Gawrieh • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC